H2AJ and cancer: This result is consistent with work showing that H2AFJ is in a genomic region that tends to show copy number amplification in luminal B cancers, and the H2AFJ gene itself tends to be hypo-methylated and over-expressed in these cancers, leading to the suggestion that it might be a luminal-B oncogene [7].